HEALING SURGICAL WOUNDS WITH HUMAN PLASMA
Haemacure is developing human biological products for use during surgery to stop bleeding, seal tissues, and speed healing.
Hub Controls
  • Upload Photo
  • Edit Company Profile
  • Add a Link
  • Update Fast Facts
  • Add Management Bios
  • Private Messages
  • Edit My Profile
  • View/Edit My Portfolio
AGORACOM News Flash

AGORACOM Launches Portfolio Feature!

We are proud to announce that the much anticipated Portfolio feature is now live.  Track your favorite US and Canadian stocks in one place., as well as, market indices and even your net wealth.

To access your portfolio, click on "My AGORACOM" at the very top of the page, and then click on "Portfolio" in the left hand navigation.

You can also access your portfolio by clicking on the "View/Edit My Portfolio" from within your "HUB Controls" on the left side of the page.

Thank-you for making AGORACOM the best small-cap community on the web.  Look for more great tools and updates to help you.  Post comments and feedback to George's blog.

Regards,
George, Paul and the AGORACOM Team

Haemacure Corporation > Message
Generic_profile

Re: Government Approvals

Posted by: AGORACOM on May 05, 2008 08:33AM

Dear sparky 69 thank you for the inquiry. Haemacure is scheduled to begin pivotal Phase II - III trials for its fibrin sealant during the first quarter of 2009 and is aiming to receive regulatory approval in the US and Europe toward the end of 2010, or the beginning of 2011.

Regards,

AGORACOM Investor Relations

Post a Reply

Please login to reply to this message.

Executive Address
Hae-galli-bc
Joseph Galli
CEO
July 07, 2008

A recent interview with the CEO discussing the company's progress

View Broadcast